No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes

Neurosci Lett. 2005 Mar 3;375(3):178-80. doi: 10.1016/j.neulet.2004.11.009. Epub 2004 Dec 10.

Abstract

Reactive oxygen species derived from dopamine metabolism can induce oxidative stress and thus may contribute to Parkinson's disease (PD) pathogenesis. The quinone oxidoreductases, nicotinamide adenine dinucleotide (phosphate) (NAD[P]H): quinone oxidoreductase 1 (NQO1) and dihydronicotinamide riboside (NRH): quinone oxidoreductase 2 (NQO2) detoxify quinones and quinonoid compounds. We investigated associations of genetic polymorphisms of NQO1 (C609T) and NQO2 (I/D, 29 base pairs) with PD in a population-based case-control study of 190 idiopathic PD cases and 305 unrelated controls matched on age and sex. No associations were detected for either gene variant or for any allele combinations.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Alleles
  • Case-Control Studies
  • Confidence Intervals
  • Female
  • Genotype
  • Humans
  • Male
  • Molecular Sequence Data
  • NAD(P)H Dehydrogenase (Quinone) / genetics*
  • Odds Ratio
  • Parkinson Disease / genetics*
  • Polymorphism, Genetic*
  • Quinone Reductases / genetics*

Substances

  • NAD(P)H Dehydrogenase (Quinone)
  • NQO1 protein, human
  • NRH - quinone oxidoreductase2
  • Quinone Reductases